本页面由Tiger Trade Technology Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

467.16
-4.5900-0.97%
成交量:46.93万
成交额:2.19亿
市值:107.71亿
市盈率:-32.86
高:478.85
开:471.75
低:460.22
收:471.75
52周最高:615.00
52周最低:393.61
股本:2,305.55万
流通股本:1,372.50万
量比:1.54
换手率:3.42%
股息:- -
股息率:- -
每股收益(TTM):-14.2164
每股收益(LYR):-12.8501
净资产收益率:-53.31%
总资产收益率:-17.84%
市净率:20.57
市盈率(LYR):-36.35

数据加载中...

2024/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

重要事件披露

Form 8-K - Current report
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/25

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/20

重要事件披露

Form 8-K - Current report
2024/03/15

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

SEC问询函

Form CORRESP - Correspondence
2024/01/09

重要事件披露

Form 8-K - Current report
2023/12/14

SEC问询函

Form CORRESP - Correspondence
2023/12/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/08

SEC问询函

Form CORRESP - Correspondence